Trypanothione as a Target in the Design of Antitrypanosomal and Antileishmanial Agents

E-ISSN： 1873-4286|7|12|1117-1141

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.7, Iss.12, 2001-08, pp. : 1117-1141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bimane cyclic esters, possible stereologues of trypanothione as antitrypanosomal agents. Bimanes 29

By Kosower E. Radkowsky A. Fairlamb A. Croft S. Neal R.

European Journal of Medicinal Chemistry, Vol. 30, Iss. 9, 1995-01 ,pp. : 659-671

Elsevier

Access to resources Recommend Favorite

Enzymes of the Trypanothione Metabolism as Targets for Antitrypanosomal Drug Development

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 11, 2002-11 ,pp. : 1239-1259

Bentham Science Publishers

Access to resources Recommend Favorite

Novel antitrypanosomal agents

By Steverding Dietmar Tyler Kevin M

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 8, 2005-08 ,pp. : 939-955

Informa Healthcare

Access to resources Recommend Favorite

Mechanisms of Drug Action and Drug Resistance in Leishmania as Basis for Therapeutic Target Identification and Design of Antileishmanial Modulators

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 5, 2006-03 ,pp. : 539-550

Bentham Science Publishers

Access to resources Recommend Favorite

Tailored Multi-Target Agents. Applications and Design Considerations

Current Pharmaceutical Design, Vol. 22, Iss. 21, 2016-06 ,pp. : 3164-3170

Bentham Science Publishers

Access to resources Recommend Favorite